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Background – Contagious ovine digital dermatitis (CODD) is an important cause of infectious lameness in sheep
in the UK and Ireland and has a severe impact on the welfare of affected individuals. The three treponemal phy-
logroups Treponema medium/Treponema vincentii-like, Treponema phagedenis-like and Treponema pedis spiro-
chaetes have been associated with clinical CODD lesions and are considered to be a necessary cause of disease.
There are scant data on the antimicrobial susceptibility of the treponemes cultured from CODD lesions.
Objective – The aim of this study was to determine in vitro the miniumum inhibitory concentration/ minimum
bactericidal concentration (MIC/MBC) of antimicrobials used in the sheep industry for isolates of the three CODD
associated treponeme phylogroups T. medium/T. vincentii-like, T. phagedenis-like and T. pedis.
Animals – Twenty treponeme isolates; from 19 sheep with clinical CODD lesions.
Methods – A microdilution method was used to determine in vitro the MIC/MBC of 10 antimicrobial agents for
20 treponeme isolates (five T. medium/T. vincentii-like, 10 T. phagedenis-like and five T. pedis). The antimicro-
bials tested were penicillin G, amoxicillin, oxytetracycline, tilmicosin, lincomycin, spectinomycin, tylosin, tildipiro-
sin, tulathromycin and gamithromycin.
Results – The treponeme isolates tested showed low MICs and MBCs to all 10 antimicrobials tested. They were
most susceptible to gamithromycin and tildipirosin (MIC90: 0.0469 mg/L), and were least susceptible to lin-
comycin, spectinomycin and oxytetracycline (MIC90: 48 mg/L, 24 mg/L and 3 mg/L, respectively).
Conclusions – These data are comparable to in vitro antimicrobial susceptibility data for treponemes cultured
from bovine digital dermatitis lesions. Dependent on local licensing, penicillin and tilmicosin appear to be the best
candidates for future in vivo studies.
Introduction
Contagious ovine digital dermatitis (CODD) is a cause of
infectious lameness in sheep in the UK and Ireland and
has been shown to have a severe impact on the welfare
of affected individuals.1 Recent surveys have shown that
CODD may affect approximately 35% of flocks in the UK;
while on-farm prevalence is typically low, it may affect up
to 50% of the flock at any one time.1
Information about the microbial flora of CODD lesions
is limited, although the bovine digital dermatitis (BDD)
associated treponemes Treponema medium/T. vincentii-
like, Treponema phagedenis-like and Treponema pedis
are currently considered to be a necessary cause of dis-
ease.1 The recent characterization of treponemes associ-
ated with CODD demonstrated the presence of at least
one BDD phylotype present in all 58 lesions studied,
whereas these were totally absent from all healthy sheep
foot tissues.2
There has been a wide range of empirically chosen
treatments employed in clinical cases such as parenteral
oxytetracycline and topical tylosin,3 with only one ran-
domized controlled trial conducted comparing parenteral
amoxicillin and simultaneous topical chlortetracycline
with topical chlortetracycline alone.4
As with CODD, the successful treatment of BDD has
remained problematic with many farms adopting manage-
ment and control strategies as opposed to affecting a
cure.5 In order to inform the development of effective
therapeutic strategies for clinical cases of CODD, a
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greater understanding is required of the susceptibility of
the treponemes found in CODD lesions to antimicrobials
currently available for use in sheep.
The aim of this study was to determine the minimum
inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) of a panel of antimicrobials for rep-
resentatives from each of the three treponeme phy-




Twenty treponeme isolates from CODD lesions from 19 sheep from
six farms in England, Wales and Northern Ireland were used
(Table 1). Included were five isolates from the T. medium/T. vincen-
tii-like group, 10 isolates from the T. phagedenis-like group and five
isolates from the T. pedis group.
In vitro antimicrobial susceptibility testing
The MIC/MBC for each antimicrobial was determined using a broth
microdilution method as previously described.6 One small adjust-
ment was made to the method such that prior to inoculation, bacte-
rial counts were assessed by determining the optical density (OD) of
the cultures using spectrometry with wavelength set at 540 nm. The
T. medium/T. vincentii-like cultures had an OD of 0.25; the T. phage-
denis-like cultures had an OD of 0.43 and the T. pedis cultures had
an OD of 0.37. This corresponds to 8.75 9 107, 1.14 9 108 and
2.69 9 108 treponemal organisms/mL, respectively.6 At this time
point, cultures were assessed by phase contrast microscopy to
determine that the cultures were alive, of the correct morphology
and lacking contaminants. The antimicrobials and their test ranges
are listed in Table 2.
Determination of MICs
The MIC for each antimicrobial was taken as the lowest concentra-
tion of antimicrobial that prevented growth in the wells observed at
the same time points.6 Cell growth was determined by comparison
of the absorbance measurement immediately after inoculation with
the absorbance measured at the late exponential/early stationary
phase. All of the absorbance measurements were at 540 nm using a
Multiskan microtitre plate reader (Thermo Scientific; Hampshire, UK).
The MIC values were taken as the median of three repeat experi-
ments, performed on different days.
Determination of MBCs
The MBC for each antimicrobial was determined as previously
described.6
Determination of MIC90 and MBC90
The cumulative inhibitory/bactericidal concentration for each antimi-
crobial tested across all the treponeme isolates was expressed as
the concentration at which 90% of CODD-associated treponemes
were inhibited from growing (MIC90) or killed (MBC90).
Statistical analysis
Differences in MICs between the three different treponeme phy-
logroups were assessed using the Kruskal–Wallis test. The
Kruskal–Wallis test and the nonparametric equality-of-medians test
were used to compare the MICs for penicillin, oxytetracycline, lin-
comycin and spectinomycin with previous data,6 and for amoxi-
cillin and gamithromycin.7 All statistical analyses were conducted
using Stata IC 13 (Stata Corp; College Station, TX, USA) and sta-
tistical significance was set at P < 0.05.
Study validation
The MIC microdilution method described in this study was validated
by comparing the results produced from four antimicrobials (peni-
cillin, oxytetracycline, lincomycin and erythromycin) incubated with
two control microorganisms T. phagedenis biotype Reiter and
T. phagedenis-like T320A against results previously obtained using a
macrodilution method8 and also results obtained using a similar
microdilution method.6,7 The data were also compared statistically
using linear regression.
Results
Antimicrobial susceptibilities of CODD-associated
treponemes
The individual MIC/MBCs of the antimicrobial agents to
each treponeme isolate are summarized in Tables 2 and
3; in this study all isolates showed low MIC/MBCs to all
Table 1. Treponemes tested for susceptibility to antimicrobial agents
Strain no. Strain Isolation date UK Location Nearest related organism*
1 G1F7C5 07/2013 Conwy Treponema medium/Treponema vincentii
2 G1F9C27 07/2013 Conwy Treponema medium/Treponema vincentii
3 G1OV11 08/2009 Gloucester Treponema medium/Treponema vincentii
4 G2S2R 02/2009 Cheshire Treponema medium/Treponema vincentii
5 ST27 07/2013 Conwy Treponema medium/Treponema vincentii
6 3F2 02/2014 Anglesey Treponema phagedenis
7 C2F 06/2009 Gloucestershire Treponema phagedenis
8 G2S4F 02/2009 Cheshire Treponema phagedenis
9 G2F3C12 07/2013 Conwy Treponema phagedenis
10 G13F3 02/2014 Denbighshire Treponema phagedenis
11 G2SL1 05/2014 Anglesey Treponema phagedenis
12 G23F1 02/2014 Anglesey Treponema phagedenis
13 S3R2 03/2009 Cheshire Treponema phagedenis
14 G2ST24 07/2013 Conwy Treponema phagedenis
15 C2R 06/2009 Gloucestershire Treponema phagedenis
16 Ovine (G179) 2000 Northern Ireland Treponema pedis
17 G3ST1 07/2014 Shrewsbury Treponema pedis
18 G3S45 07/2014 Shrewsbury Treponema pedis
19 G3T1 07/2014 Shrewsbury Treponema pedis
20 G3T7 07/2014 Shrewsbury Treponema pedis
*As determined by 16S rRNA gene phylogenetic analysis.
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Penicillin Amoxicillin Oxytetracycline Tilmicosin Lincomycin Spectinomycin Tildipirosin Tulathromycin Gamithromycin Tylosin
1 0.0750 0.5625 3 0.0703 24 12 0.0234 0.2930 0.0469 0.0469
2 0.0375 0.2813 3 0.0234 48 24 0.0234 0.2930 0.0234 0.0234
3 0.0375 0.5625 1.5 0.0117 48 12 0.0469 1.1719 0.0469 0.0234
4 0.0750 0.2813 1.5 0.0234 24 12 0.0469 0.2930 0.0234 0.0469
5 0.0750 0.5625 3 0.0117 24 24 0.0469 1.1719 0.0469 0.0469
6 0.0375 0.1406 0.75 0.0234 24 12 0.0469 0.5859 0.0469 0.0469
7 0.0188 0.1406 0.75 0.0469 12 12 0.0938 0.5859 0.0117 0.0469
8 0.0750 0.2813 0.375 0.0094 12 12 0.0469 0.2930 0.0117 0.0469
9 0.0375 0.1406 0.75 0.1875 24 12 0.0469 0.5859 0.0234 0.1875
10 0.0188 0.1406 0.75 0.0234 6 12 0.0117 0.5859 0.0469 0.0469
11 0.0188 0.2813 0.75 0.0234 3 6 0.0938 0.1465 0.0117 0.0469
12 0.0750 0.1181 0.375 0.0059 6 3 0.0469 0.2930 0.0029 0.0059
13 0.0375 0.1181 0.375 0.375 12 12 0.0234 0.5859 0.0938 0.1875
14 0.0750 0.1181 0.375 0.0938 48 12 0.0234 0.5859 0.0938 0.0234
15 0.0188 0.1406 1.5 0.1875 96 24 0.0469 0.2930 0.0234 0.0938
16 0.0750 0.2813 1.5 0.0234 24 24 0.0234 0.5859 0.0234 0.0938
17 0.0375 0.5625 6 0.0234 48 24 0.0234 0.5859 0.0469 0.0469
18 0.0750 0.5625 3 0.0234 48 12 0.0469 0.5859 0.0234 0.0469
19 0.0750 0.2813 1.5 0.0117 48 24 0.0469 0.5859 0.0234 0.0938
20 0.0750 0.5625 6 0.0117 96 24 0.0234 1.1719 0.0234 0.0938
MIC90
† 0.0750 0.5625 3 0.1875 48 24 0.0469 1.1719 0.0469 0.0938
*Isolates 1–5 are Treponema medium/Treponema vincentii-like BDD spirochaetes with antibiotic test ranges (lg/L) of: penicillin G 0.75–0.0059;
amoxicillin 2.25–0.0176; oxytetracycline 12–0.0938; tilmicosin 0.375–0.0029; lincomycin 192–1.5; spectinomycin 48–0.375 (Sigma-Aldrich; Dorset,
UK); tildipirosin 0.75–0.0059 (Zuprevo, MSD Animal Health; Milton Keynes, UK); tulathromycin 9.375–0.0732 (Draxxin, Zoetis UK Limited; London,
UK); gamithromycin 0.188–0.0015 (Merial LLC; Duluth, Georgia, USA); and tylosin 0.375–0.0029 (Sigma-Aldrich).
Isolates 6–15 are Treponema phagedenis-like CODD spirochaetes and isolates 16–20 are Treponema pedis CODD spirochaetes with test ranges
the same as those for Treponema medium/Treponema vincentii-like BDD spirochaetes.
†Cumulative susceptibility results across all treponemes tested are expressed as MIC90, the concentration at which 90% of CODD-associated tre-
ponemes were inhibited.





Penicillin Amoxicillin Oxytetracycline Tilmicosin Lincomycin Spectinomycin Tildipirosin Tulathromycin Gamithromycin Tylosin
1 0.0750 0.5625 6 0.0938 48 12 0.0469 0.5859 0.0469 0.0938
2 0.0750 0.5625 3 0.0469 96 24 0.0469 0.2930 0.0469 0.0938
3 0.0750 1.1250 3 0.0234 48 24 0.0469 1.1719 0.0469 0.0938
4 0.0750 0.5625 3 0.0469 48 24 0.0469 0.5859 0.0234 0.0938
5 0.0750 0.5625 6 0.0234 24 24 0.0469 1.1719 0.0469 0.0938
6 0.0375 0.5625 6 0.0469 48 12 0.0938 0.5859 0.0469 0.3750
7 0.0375 0.5625 3 0.1875 24 24 0.0938 0.5859 0.0234 0.0938
8 0.0750 0.5625 3 0.1875 24 12 0.0469 1.1719 0.0234 0.3750
9 0.0750 0.5625 6 0.1875 96 24 0.0938 0.1172 0.0469 0.1875
10 0.0375 0.2813 6 0.0234 96 12 0.0234 0.5859 0.0469 0.0469
11 0.0189 0.2813 3 0.0234 48 6 0.3750 0.5859 0.0117 0.0469
12 0.0750 0.2813 1.5 0.0117 24 6 0.0469 0.5859 0.0117 0.0117
13 0.0375 0.1181 0.75 0.1875 24 12 0.0234 1.1719 0.0938 0.1875
14 0.0750 0.5625 0.375 0.0938 48 12 0.0234 0.5859 0.0938 0.0938
15 0.0188 0.2813 0.75 0.1875 24 12 0.0469 0.5859 0.0234 0.0938
16 0.0750 0.5625 3 0.0234 48 24 0.0469 0.5859 0.0469 0.0938
17 0.0750 0.5625 6 0.0234 96 24 0.0469 0.5859 0.0469 0.0938
18 0.0750 0.5625 6 0.0469 48 12 0.0469 1.1719 0.0234 0.0938
19 0.0750 0.5625 6 0.0469 48 24 0.0469 1.1719 0.0469 0.0938
20 0.0750 0.5625 6 0.0234 96 24 0.0234 1.1719 0.0469 0.0938
MBC90
† 0.0750 0.5625 6 0.1875 96 24 0.0938 1.1719 0.0469 0.1875
*1–5, Treponema medium/Treponema vincentii-like; 6–15, Treponema phagedenis-like; 16–20, Treponema pedis.
†Cumulative susceptibility results across all treponemes tested are expressed as MBC90, the concentration at which 90% of CODD-associated
treponemes were killed.
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of the antimicrobials tested. Using Table 2, all treponeme
groups were most susceptible to gamithromycin and tildi-
pirosin, and least susceptible to lincomycin, spectino-
mycin and oxytetracycline. The MIC90 for the other five
antimicrobials were all relatively low, being <1.0 lg/mL.
No bimodal distributions were identified.
Variation in MIC across the different treponeme
phylogroups
There was no significant difference in MIC values
between the three different phylogroups for five of the
seven macrolides (P = 0.2), with phylogroup differences
for lincomycin and spectinomycin approaching signifi-
cance (P = 0.05). Whilst there was no significant differ-
ence between phylogroups in the case of penicillin MIC
(P = 0.1), in the case of amoxicillin and oxytetracycline,
T. phagedenis-like bacteria were more susceptible com-
pared to T. medium/T. vincentii-like and T. pedis (P =
0.002 and P = 0.001, respectively).
Comparisons with data from previous studies
The MICs for penicillin, oxytetracycline, lincomycin,
spectinomycin, amoxicillin and gamithromycin for the 20
isolates investigated here, were not significantly different
to those previously reported.6,7
Study validation
The comparison described matched the previous results
in all cases except for one antimicrobial (oxytetracycline),
which was different by one serial dilution when compared
with the macrodilution method.8 Linear regression for
these comparisons showed strong correlations (R = 0.99
P < 0.004) indicating the efficacy and reproducibility of
this microdilution method.
Discussion
Study validation and comparisons with data from
previous studies
The methodological validations described reinforce the
comparable nature of these current data with previous
studies. Comparisons of these current data for penicillin,
oxytetracycline, lincomycin and spectinomycin with previ-
ous studies do not reveal any statistically significant dif-
ferences.6,7 Therefore, these current data make a
valuable contribution to the available data on the in vitro
antimicrobial susceptibility of these treponemes.
Antimicrobial use in sheep with CODD
All of the isolates in this study were susceptible (in vitro)
to all the antimicrobials tested, with gamithromycin, tildi-
pirosin, penicillin, tylosin and tilmicosin demonstrating the
lowest MICs and MBCs. This susceptibility, however,
may not necessarily be reflected in vivo. To date, there
have been very few robust in vivo studies examining
effective treatment. In two clinical studies4,9 systemic
amoxicillin together with topical chlortetracycline was
found to have a clinical cure rate in clinical cases of CODD
of approximately 80%. Anecdotally, systemic tilmicosin
was also proposed to be an effective treatment for sheep
with CODD10 and systemic oxytetracycline together with
a tylosin footbath were considered to be an effective pre-
ventative method.3
Currently, no antimicrobial product has a license for
CODD in the UK. The antimicrobials studied here were
selected to include antimicrobials that already have a
license for sheep (penicillin, amoxicillin, oxytetracycline
and tilmicosin) together with those that in the authors’
experience are already used (off label) in the sheep indus-
try. Therefore, given this context and these data as a
whole, penicillin and tilmicosin would appear to be the
most likely candidates for future in vivo studies.
This study provides the first detailed examination of the
in vitro antimicrobial susceptibilities of all three associated
phylogroups of treponemes cultured from CODD lesions
to antimicrobials. As such, these data provide important
in vitro information on antimicrobials currently used to
treat this disease and should help inform researchers
planning further in vivo studies when considering which
products to include.
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Resume
Contexte – La dermatite digitale contagieuse ovine (CODD) est une cause infectieuse importante de boite-
rie chez le mouton au Royaume Uni et en Irlande et a un impact severe sur le bien e^tre des sujets atteints.
Les trois phylogroupes de spirochaetes Treponema medium/Treponema vincentii-like, Treponema phage-
denis-like et Treponema pedis ont ete associes avec des lesions cliniques de CODD et sont consideres
comme les causes obligatoires de la maladie. Il existe peu de donnees sur les sensibilites antimicrobiennes
des treponemes issus des lesions de CODD.
Objectif – Le but de l’etude etait de determiner la concentration minimale inhibitrice in vivo et la concentra-
tion bactericide minimale (MIC/MBC) des antimicrobiens utilises dans l’industrie ovine pour les souches
des trois phylogroupes de treponemes associes au CODD T. medium/T. vincentii-like, T. phagedenis-like
et T. pedis.
Sujets – Vingt souches de treponeme, issues de 19 moutons presentant des lesions de CODD.
Methodes – Une methode de microdilution a ete utilisee pour determiner le MIC/MBC in vitro de 10
agents antimicrobiens pour 20 souches de treponemes (cinq T. medium/T. vincentii-like, 10 T. phagede-
nis-like et cinq T. pedis). Les antimicrobiens testes etaient la penicilline G, l’amoxicilline, l’oxytetracycline,
la tilmycosine, la lincomycine, la spectinomycine, la tylosine, la tildipirosine, la tulathromycine et la gami-
thromycine.
Resultats – Les souches de treponemes testees ont montre de faibles MIC et MBC a tous les 10 antimi-
crobiens. Elles etaient plus sensibles a la gamithromycine et la tildipirosine (MIC90: 0.0469 mg/L), et
etaient au moins sensibles a la lincomycine, la spectinomycine et l’oxytetracycline (MIC90: 48, 24 and
3 mg/L, respectivement).
Conclusions – Ces donnees sont comparables aux donnees de sensibilite aux antimicrobiens in vitro pour
les treponemes issus de lesions podales des bovins. En fonction des autorisations locales, la penicilline et
la tilmicosine semblent e^tre les meilleures options pour de prochaines etudes in vivo.
Resumen
Introduccion – la dermatitis contagiosa digital ovina (CODD) es una causa importante de de cojera infec-
ciosa en ovejas en el Reino Unido e Irlanda y tiene un impacto severo en la salud de los individuos afecta-
dos. Los tres filogrupos de espiroquetas de Treponema Treponema medium/Treponema similar a
T. vincentii, Treponema similar a T. phagenedis y Treponema pedis han sido asociados con lesiones clıni-
cas de CODD y estan considerados como una causa necesaria de enfermedad. Hay pocos datos acerca de
la susceptibilidad antimicrobiana de los cultivos de Treponema obtenidos de lesiones de CODD.
Objetivo – el proposito de este estudio fue determinar la concentracion inhibitoria mınima/concentracion
mınima bactericida (MIC/MBC) in vitro de antimicrobianos utilizados en la industria ovina frente a asilados
de los tres filogrupos de Treponema asociados con CODD Treponema medium/Treponema similar a T. vin-
centii, Treponema similar a T. phagenedis y Treponema pedis.
Animales – 20 aislados de Treponema de 19 ovejas con lesiones clınicas de CODD.
Metodos – se utilizo un metodo de microdilucion para determinar la MIC/MBC in vitro de 10 agentes anti-
microbianos frente a 20 aislados de Treponema (cinco Treponema medium/Treponema similar a T. vincen-
tii, diez de Treponema similar a T. phagenedis y cinco de Treponema pedis). Los antimicrobianos probados
fueron penicilina G, amoxicilina, oxitetraciclina, tilmicosina, lincomicina, espectinomicina, tilosina, tildipiro-
sina, tulatromicina y gamitromicina.
Resultados – los asilados de Treponema probados mostraron bajas MICs y MBCs en los 10 antimicrobia-
nos probados. Fueron mas susceptibles a gamitromicina y tildipirosina (MIC90: 0,0469 mg/L) y fueron
menos susceptibles a lincomicina, espectinomicina y (MIC90: 48, 24, y 3 mg/L respectivamente.
Conclusiones e importancia clınica – estos datos son comparables a la susceptibilidad antimicrobiana
in vitro de Treponemas cultivados de lesiones dermales digitales bovinas. Dependiendo de las licencias
locales, la penicilina y tilmicosina pueden ser los mejores candidatos para futuros estudios in vivo.
Zusammenfassung
Hintergrund – Die kontagi€ose ovine digitale Dermatitis (CODD) ist eine wichtige Ursache f€ur infekti€ose
Lahmheit bei Schafen im Vereinigten K€onigreich und in Irland und hat gravierende Einfl€usse auf das Wohl-
befinden der betroffenen Tiere. Die drei Phylogruppen der Treponema, Treponema medium/Treponema
vincentii-like, Treponema phagedenis-like und Treponema pedis Spiroch€aten sind mit klinischen CODD
Ver€anderungen in Zusammenhang gebracht worden und werden als notwendige Ursache f€ur eine Erkran-
kung gesehen. Es gibt nur sp€arliche Daten €uber die antimikrobielle Empfindlichkeit der Treponema, die aus
CODD Ver€anderungen kultiviert wurden.
Ziel – Das Ziel dieser Studie war es, die minimale inhibitorische in vitro Konzentration/minimale bakterizide
Konzentration (MIC/MBC) der Antibiotika zu bestimmen, die in der Schafindustrie f€ur Isolate der CODD ver-
ursachenden Treponema Phylogruppen, T. medium/T. vincentii-like, T. phagedenis-like und T. pedis Ver-
wendung finden.
Angell et al.
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Tiere – Zwanzig Treponema Isolate; von 19 Schafen mit klinischen CODD Ver€anderungen.
Methoden – Eine Mikrodilutionsmethode wurde angewendet, um die in vitroMIC/MBC von 10 Antibiotika
f€ur 20 Treponema Isolate (f€unf T. medium/T. vincentii-like, 10 T. phagedenis-like und f€unf T. pedis) zu
bestimmen.
Ergebnisse – Die getesteten Treponema Isolate zeigten niedrige MICs und MBCs gegen€uber allen 10
getesteten Antibiotika. Sie waren gegen€uber Gamithromycin und Tildipirosin empfindlicher (MIC90: 0,0469
mg/L, und waren am wenigsten empfindlich gegen€uber Lincomycin, Spectinomycin und Oxytetracyclin
(MIC90: 48, 24 bzw. 3 mg/L).
Schlussfolgerungen – Diese Daten sind mit den in vitro antimikrobiellen Empfindlichkeitsdaten f€ur Trepo-
nema, die aus bovinen digitalen Hautver€anderungen kultiviert wurden, vergleichbar. Je nach lokaler Zulas-






目的 – この研究の目的はCODDに関連した3つのトレポネーマ統計群であるT. medium/T. vincentii-like,
T. phagedenis-like および T. pedis.の分離菌に対して養羊業界で使用する抗菌剤のin vitroの最小阻止濃度/
最小細菌濃度(MIC/MBC)を明らかにすることである。
供与動物 – 臨床的にCODDの症状を示す19頭の羊から分離した20種類のトレポネーマ分離菌






チノマイシン、およびテトラサイクリンに対しては最も感受性が低かった(それぞれのMIC90は48 mg/L, 24 mg/L and 3
mg/L)。







目的 – 研究的目的,是确定引起CODD的三种菌株:Treponema medium/文氏密螺旋体、梅毒密螺旋体和足
密螺旋体,其抗菌剂的体外最小抑菌浓度和最小杀菌浓度(MIC/MBC)。
动物 – 从具有CODD临床病变的10只绵羊上分离20份密螺旋体菌株。
方法–使用微稀释法确定10种抗菌剂分别对20份密螺旋体菌株(5株 T. medium/T. vincentii-like, 10株 T.
phagedenis-like 和 5株T. pedis)的体外MIC/MBC。参与检测的抗菌剂分别为青霉素G、阿莫西林、土霉
素、替米考星、林可霉素、大观霉素、泰勒菌素、泰地罗斯、泰拉霉素和加米霉素。
结果 –密螺旋体的菌株测试显示,10种抗菌药物均有较低的MICs和MBCs。最敏感的抗菌药物为加米霉素和
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